Protein oxidation status in patients with ankylosing spondylitis

Rheumatology

Volumn 43, Issue 10, 2004, Pages 1235-1239

  Yazici, C ^a   Kose K ^a   Calis, M ^a   Kuzuguden S ^a   Kirnap, M ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Advanced oxidation protein products; Ankylosing spondylitis; Myeloperoxidase; Neutrophil activation; Protein oxidation

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; HYPOCHLOROUS ACID; MYELOPEROXIDASE; NONSTEROID ANTIINFLAMMATORY AGENT; OXIDIZING AGENT; THIOL;

ADOLESCENT; ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; CHLORINATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; MALE; NEUTROPHIL; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN METABOLISM; SPINE DISEASE; STATISTICAL SIGNIFICANCE; VISUAL ANALOG SCALE; VOLUNTEER;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD CELL COUNT; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; PAIN MEASUREMENT; PEROXIDASE; PROTEINS; SPONDYLITIS, ANKYLOSING; SULFHYDRYL COMPOUNDS;

EID: 5444227111     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh317     Document Type: Article

References (31)

1. Arnett FC. Ankylosing spondylitis. In: Koopman WJ, ed. Arthritis and allied conditions: a textbook of rheumatology, 13th edn. Vol. 1. Baltimore: Williams & Wilkins, 1997:1197-208.
2. Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A. Ankylosing spondylitis: an overview. Ann Rheum Dis 2002;61(Suppl. 3):iii8-18.
3. Repo H, Leirisalo-Repo M, Koivuranta-Vaara P. Exaggerated inflammatory responsiveness plays a part in the pathogenesis of HLA-B27 linked diseases-hypothesis. Ann Clin Res 1984;16:47-50.
4. Pease CT, Fennell M, Brewerton DA. Polymorphonuclear leukocyte motility in men with ankylosing spondylitis. Ann Rheum Dis 1989; 48:35-41.
5. Ho KJ, Chen PQ, Chang CY, Lu FJ. The oxidative metabolism of circulating phagocytes in ankylosing spondylitis: determination by whole blood chemiluminescence. Ann Rheum Dis 2000;59:338-41.
6. el Abbouyi A, Paul JL, Roch-Arveiller M et al. Blood polymorphonuclear behavior in patients with ankylosing spondylitis. Clin Exp Rheumatol 1988;6:401-3.
7. Shen SY, Tsuang YH, Hsu FL, Lu FJ, Chiang HC. Superoxide anion scavenge effect of Quercus glauca Thunb. in whole blood of patients with ankylosing spondylitis. Am J Chin Med 1997;25:307-5.
8. Sies H. Oxidative stress; oxidants and antioxidants. Exp Physiol 1997;82:291-5.
9. Ozgocmen S, Sogut S, Ardicoglu O, Fadillioglu E, Pekkutucu I, Akyol O. Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis. Rheumatol Int 2004;24:80-3.
10. Mezes M, Par A, Bartosiewicz G, Nemeth J. Vitamin E content and lipid peroxidation of blood in some chronic inflammatory diseases. Acta Physiol Hung 1987;69:133-8.
11. Mitrofanova OV, Bagirova VV, Krasikov SI. Level of lipid peroxidation products and activity of antiradical defense enzymes in blood of patients with Bechterew disease. Ter Arkh 2002;74:66-9.
12. Massy ZA, Nguyen-Khoa T. Oxidative stress and chronic renal failure: markers and management. J Nephrol 2002;15:336-41.
13. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 2003;329:23-38.
14. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304-13.
15. Himmelfarb J, McMonagle E, McMenamin E. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int 2000;58:2571-8.
16. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
17. Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Dougados M. Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology 1999;38:878-82.
18. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206-9.
19. Hu ML, Louie S, Cross CE, Motchnik P, Halliwell B. Antioxidant protection against hypochlorous acid in human plasma. J Lab Clin Med 1993;121:257-62.
20. Munoz-Villanueva MC, Munoz-Gomariz E, Escudero-Contreras A, Perez-Guijo V, Collantes-Estevez E. Biological and clinical markers of disease activity in ankylosing spondylitis. J Rheumatol 2003;30: 2729-32.
21. Reinisch N, Mur F, Herold M et al. Decrease of respiratory burst in neutrophils of patients with ankylosing spondylitis by combined radon-hyperthermia treatment. Clin Exp Rheumatol 1999;17:335-8.
22. Wendling D, Didier JM, Vuitton DA. The phagocyte oxidative metabolism function in ankylosing spondylitis. Rheumatol Int 1991; 11:187-9.
23. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L. Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 2000;80:617-53.
24. Edwards SW, Hallett MB. Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis. Immunol Today 1997; 18:320-4.
25. Capeillère-Blandin C, Gausson V, Descamps-Latscha B, Witko-Sarsat V. Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochim Biophys Acta 2004;1689:91-102.
26. Witko-Sarsat V, Friedlander M, Nguyen Khoa T et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998;161: 2524-32.
27. Halliwell B, Gutteridge JM. The antioxidants of human extracellular fluids. Arch Biochem Biophys 1990;280:1-8.
28. Zoschke DC, Kaja J. Suboptimal levels of hydrogen peroxide scavengers in synovial fluid: in vitro augmentation with slow acting antirheumatic drugs. J Rheumatol 1989;16:1233-40.
29. McCarty DJ. Synovial fluid. In: Koopman WJ, ed. Arthritis and allied conditions: a textbook of rheumatology, 13th edn. Vol. 1. Baltimore: Williams & Wilkins, 1997:81-102.
30. Abbink JJ, Kamp AM, Nieuwenhuys EJ, Nuijens JH, Swaak AJ, Hack CE. Predominant role of neutrophils in the inactivation of alpha 2-macroglobulin in arthritic joints. Arthritis Rheum 1991;34: 1139-50.
31. Johansson MW, Patarroyo M, Öberg F, Siegbahn A, Nilsson K. Myeloperoxidase mediates cell adhesion via the alpha M beta 2 integrin (Mac-1, CD11b/CD18). J Cell Sci 1997;110:1133-9.